Patents Assigned to Intermune Life Sciences, Inc.
  • Immune cell proliferation inhibitors
    Patent number: 5256411
    Abstract: A method for treating an immune system disorder in a human by administering to the human a therapeutically effective amount of an active substance selected from the group consisting of PP14, derivatives of PP14, muteins of PP14, fragments of PP14, and subunits of PP14, to alleviate the immune system disorder.
    Type: Grant
    Filed: June 28, 1991
    Date of Patent: October 26, 1993
    Assignee: Intermune Life Sciences, Inc.
    Inventors: Anthony E. Bolton, Alan Drizen